debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
Published 8 years ago • 865 plays • Length 4:53Download video MP4
Download video MP3
Similar videos
-
12:47
debate: salvage therapy for mcrc? regorafenib followed by tas-102
-
13:46
debate 3: salvage therapy for mcrc? - tas-102
-
11:02
debate 3: salvage therapy for mcrc? - regorafenib
-
7:54
regorafenib vs tas-102 salvage therapy
-
9:06
debate: is there an optimal treatment for refractory colorectal cancer? - tas-102 or regorafenib
-
8:44
debate: optimal salvage therapy for refractory colon cancer? - tas102 or regorafenib
-
4:54
the first oral fluoropyrimidine for mcrc—tas-102
-
7:20
debate: optimal salvage therapy for refractory colon cancer? - immunotherapy
-
2:13
later-line treatment for mcrc: regorafenib or tas-102?
-
1:35
dr. lockhart on next steps for regorafenib and tas-102 in mcrc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
2:47
mcrc: sequencing with regorafenib or tas-102
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
18:55
emerging treatment options for mcrc patients in the late-line setting
-
2:06
howard s. hochster, md, differentiates regorafenib from 5fu and tas-102
-
0:42
dr. bendell on the future of regorafenib for patients with crc